| Indicators | Browse All

SL Science Holding Limited (SLBT)

Healthcare | Biotechnology | Taipei, Taiwan | NasdaqGM
1.53 USD -0.02 (-1.290%) ⇩ (Oct. 16, 2026, 4 p.m. EDT)

Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 1:28 a.m. EDT

The immediate outlook is severely clouded by a massive 35% drop in 2025 revenue and a complete absence of profitability, with operating cash flow burning through reserves. While the company recently secured a significant stakeholder backing and advanced a promising brain cancer therapy to the FDA, the financial reality is stark: the business is hemorrhaging cash, trading at a premium valuation relative to sales despite zero earnings, and showing no signs of stabilizing its top line. The recent price action suggests volatility rather than a sustainable recovery, making this a dangerous environment for near-term capital preservation.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.104429
AutoETS0.300685
MSTL0.310830
AutoARIMA0.381211

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 30%
H-stat 0.15
Ljung-Box p 0.000
Jarque-Bera p 0.004
Excess Kurtosis 1.10
Attribute Value
Sector Healthcare
Debt to Equity Ratio 6.462
Revenue per Share 0.89
Market Cap 857,962,368
Profit Margins -72.46%
Website https://www.sl-bio.com

Info Dump

Attribute Value
52 Week Change -0.852459
Address1 No. 479, Chongyang Rd.
Address2 11th Floor, Nangang Dist.
All Time High 14.5
All Time Low 1.42
Ask 4.0
Ask Size 1
Average Daily Volume10 Day 59,100
Average Daily Volume3 Month 78,700
Average Volume 78,700
Average Volume10Days 59,100
Bid 3.16
Bid Size 8
Book Value 1.287
City Taipei
Country Taiwan
Crypto Tradeable 0
Currency USD
Current Price 1.53
Current Ratio 4.899
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 1.552
Day Low 1.5
Debt To Equity 6.462
Display Name SL Science
Dividend Yield 0.0
Ebitda -2,284,772
Ebitda Margins -0.69869006
Enterprise To Ebitda -1.118
Enterprise To Revenue 0.781
Enterprise Value 2,555,127
Eps Trailing Twelve Months -0.01
Esg Populated 0
Exchange NGM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.1756
Fifty Day Average Change -0.6456001
Fifty Day Average Change Percent -0.29674575
Fifty Two Week Change Percent -85.2459
Fifty Two Week High 14.5
Fifty Two Week High Change -12.97
Fifty Two Week High Change Percent -0.8944828
Fifty Two Week Low 1.42
Fifty Two Week Low Change 0.110000014
Fifty Two Week Low Change Percent 0.077464804
Fifty Two Week Range 1.42 - 14.5
Financial Currency USD
First Trade Date Milliseconds 1,738,765,800,000
Full Exchange Name NasdaqGM
Full Time Employees 14
Fullday Change -0.01999998
Fullday Change Percent -1.3157883
Fullday Price 1.53
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.38412
Gross Profits 1,256,100
Has Pre Post Market Data 1
Held Percent Insiders 0.59545
Held Percent Institutions 0.0029300002
Implied Shares Outstanding 560,759,757
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ipo Expected Date 2,026-06-15
Language en-US
Last Fiscal Year End 1,735,603,200
Long Business Summary SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.
Long Name SL Science Holding Limited
Market us_market
Market Cap 857,962,368
Market State CLOSED
Max Age 86,400
Message Board Id finmb_1943198251
Most Recent Quarter 1,751,241,600
Net Income To Common -2,369,382
Next Fiscal Year End 1,767,139,200
Non Diluted Market Cap 908,430,806
Open 1.54
Operating Cashflow -2,954,163
Operating Margins -1.4255099
Phone 886 2 2651 6826
Previous Close 1.55
Price Hint 4
Price To Book 1.1888112
Price To Sales Trailing12 Months 262.36572
Profit Margins -0.72456
Quick Ratio 3.837
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.02
Regular Market Change Percent -1.29032
Regular Market Day High 1.552
Regular Market Day Low 1.5
Regular Market Day Range 1.5 - 1.552
Regular Market Open 1.54
Regular Market Previous Close 1.55
Regular Market Price 1.53
Regular Market Time 1,792,180,800
Regular Market Volume 24,821
Revenue Growth -0.076
Revenue Per Share 0.89
Sand P52 Week Change 0.13723719
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 560,759,757
Shares Percent Shares Out 0.0001
Shares Short 51,477
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 37,659
Short Name SL Science Holding Limited
Short Percent Of Float 0.0002
Short Ratio 0.5
Source Interval 15
Symbol SLBT
Total Cash 3,373,292
Total Cash Per Share 0.918
Total Debt 305,669
Total Revenue 3,270,101
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.01
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 6.5535
Two Hundred Day Average Change -5.0235004
Two Hundred Day Average Change Percent -0.766537
Type Disp Equity
Volume 24,821
Website https://www.sl-bio.com
Zip 115,010